Malachia Hoover - Publications

Affiliations: 
2014-2017 Biology California State University, Northridge, Los Angeles, CA, United States 

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Hoover M, Runa F, Booker E, Diedrich JK, Duell E, Williams B, Arellano-Garcia C, Uhlendorf T, La Kim S, Fischer W, Moresco J, Gray PC, Kelber JA. Identification of myosin II as a cripto binding protein and regulator of cripto function in stem cells and tissue regeneration. Biochemical and Biophysical Research Communications. PMID 30579599 DOI: 10.1016/J.Bbrc.2018.12.059  0.608
2017 Gharibi A, La Kim S, Molnar J, Brambilla D, Adamian Y, Hoover M, Hong J, Lin J, Wolfenden L, Kelber JA. ITGA1 is a pre-malignant biomarker that promotes therapy resistance and metastatic potential in pancreatic cancer. Scientific Reports. 7: 10060. PMID 28855593 DOI: 10.1038/S41598-017-09946-Z  0.724
2017 Kim SL, Gharibi A, Molnar J, Brambilla D, Adamian Y, Hoover M, Lin J, Hong J, Kelber JA. Abstract LB-149: ITGA1 marks pre-malignant pancreatic lesions and drives stem-like cell survival and TGFβ/collagen-induced therapy resistance and metastasis in pancreatic cancer Cancer Research. 77. DOI: 10.1158/1538-7445.Am2017-Lb-149  0.713
2016 Hoover M, Adamian Y, Brown M, Maawy A, Chang A, Lee J, Gharibi A, Katz MH, Fleming J, Hoffman RM, Bouvet M, Doebler R, Kelber JA. A novel method for RNA extraction from FFPE samples reveals significant differences in biomarker expression between orthotopic and subcutaneous pancreatic cancer patient-derived xenografts. Oncotarget. PMID 27602776 DOI: 10.18632/Oncotarget.11809  0.703
2016 Hoover M, Adamian Y, Brown M, Maawy AA, Hoffman R, Bouvet M, Doebler R, Kelber JA. Abstract LB-263: Analysis of microenvironment effects on pancreatic cancer biomarker expression using a novel method for FFPE RNA extraction Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Lb-263  0.805
2016 Gharibi A, Kim SL, Brambilla D, Adamian Y, Hoover M, Lin J, Agajanian M, Wolfenden L, Kelber JA. Abstract 4426: The PEAK1/ZEB1/ITGA1 pathway mediates survival, stemness and TGFbeta-induced EMT in pancreatic cancer Cancer Research. 76: 4426-4426. DOI: 10.1158/1538-7445.Am2016-4426  0.698
2015 Agajanian M, Campeau A, Hoover M, Hou A, Brambilla D, Kim SL, Klemke RL, Kelber JA. PEAK1 Acts as a Molecular Switch to Regulate Context-Dependent TGFβ Responses in Breast Cancer. Plos One. 10: e0135748. PMID 26267863 DOI: 10.1371/Journal.Pone.0135748  0.754
Show low-probability matches.